Shicong Wang

Dr. Shicong Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
QCQiang Chen
Qiang Chen
YHYilin Hong
Yilin Hong
SWShihe Weng
Shihe Weng
PGPeng Guo
Peng Guo
BLBei Li
Bei Li
PMPingli Mo
Pingli Mo
Pien Tze Huang (PZH) is a valuable traditional Chinese medicine, which has a variety of biological activities such as clearing heat-toxin, resolving blood stasis, detoxifying, relieving pain, and anti-inflammation. PZH has a partial role in suppressing the progression of CRC, while the underlying mechanism is a pending mystery; especially whether PZH mediates the immune escape of CRC remains unclear. Our study reported that PZH suppressed the proliferative activity of CRC by inhibiting Wnt/β-catenin signaling to down-regulate the expression of PCNA and Cyclin D1. In addition, PZH suppressed the immune escape of CRC and elevated the infiltration of CD8+ T cells in tumor tissues, which depends on the suppression of PD-L1 levels via inhibiting IFNGR1-JAK1-STAT3-IRF1 signaling. More importantly, PZH pharmacologically elevated the antitumor efficacy of anti-PD-1/PD-L1 immunotherapy as demonstrated by slower tumor growth, higher infiltration and function of CD8+ T cells in the combination of PZH and PD-1/PD-L1 antibody compared with monotherapy with either agent. These results demonstrate that PZH has the potential role in inhibiting CRC proliferation and immune evasion, especially the synergistic enhancement effect of PZH on immunotherapy.

24 February 2024 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
LTLiangliang Tian
Liangliang Tian
GCGuangzhao Cao
Guangzhao Cao
XZXiaotong Zhu
Xiaotong Zhu
LWLihan Wang
Lihan Wang
JHJingyi Hou
Jingyi Hou
JZJingjing Zhang
Jingjing Zhang

23 June 2026 in Translational Research
Verified
Journal Article
Closed access
SWShicong Wang
Shicong Wang
YHYi He
Yi He
BLBin Liu
Bin Liu
YZYouhong Zeng
Youhong Zeng
GOGaoliang Ouyang
Gaoliang Ouyang
TWTiantian Wu
Tiantian Wu